Y-27632 dihydrochloride is a selective Rho-kinase inhibitor, which suppresses cholinergic nerve-mediated contractions. In addition, studies show that Y-27632 dihydrochloride increases the release of neurotransmitters from cholinergic nerves. Studies conducted on smooth muscle preparations sμggest that Y-27632 dihydrochloride suppresses nerve-mediated contractile responses stimulated by acetylcholine and noradrenaline. Furthermore, studies on lung tissue damage in rats sμggest that Y-27632 dihydrochloride can restore the damage caused by oleic acid by inhibition of ROCK-1 and ROCK-2. Y-27632 dihydrochloride also inhibits protein kinase C related kinase, PRK2.A cell permeable inhibitor of ROCK-1 and ROCK-2
Y-27632 dihydrochloride is a selective Rho-kinase inhibitor, which suppresses cholinergic nerve-mediated contractions. In addition, studies show that Y-27632 dihydrochloride increases the release of neurotransmitters from cholinergic nerves. Studies conducted on smooth muscle preparations suggest that Y-27632 dihydrochloride suppresses nerve-mediated contractile responses stimulated by acetylcholine and noradrenaline. Furthermore, studies on lung tissue damage in rats suggest that Y-27632 dihydrochloride can restore the damage caused by oleic acid by inhibition of ROCK-1 and ROCK-2. Y-27632 dihydrochloride also inhibits protein kinase C related kinase, PRK2.
A cell permeable inhibitor of ROCK-1 and ROCK-2
相关属性
| CAS编号 | 129830-38-2 | 
|---|
| 敏感性 | 对湿度敏感;对光线敏感;对热敏感; | 
|---|
| 比旋光度 | +4.0° (C=1,MeOH) | 
|---|
| 熔点 | 252 °C | 
|---|
| 溶解性 | Soluble in water (14 mg/mL), ethanol (~5 mg/mL), DMSO (~20 mg/mL), DMF (~30 mg/mL), PBS, pH 7.2 (~10 mg/mL), and methanol (25 mg/mL). | 
|---|
| 储存温度 | -20°C储存,充氩 | 
|---|
| MDL号 | MFCD03490488 | 
|---|
| 分子量 | 320.26 | 
|---|
| 分子式 | C14H21N3O·2HCl | 
|---|
| 品牌 | 阿拉丁 | 
|---|
| 备注 | 如果有可能,您尽量在同一天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 | 
|---|
| 法律信息 | Sold under license from Mitsubishi Pharma Corporation | 
|---|
| PubChem CID | 9901617 | 
|---|